Area of research
Molecular Biology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, and Immune cells in cancer.
Synthesis and Structure–Activity Relationships of CRBN-Recruiting ZBTB11 Molecular Glue Degraders
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer
Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML
Bruton tyrosine kinase degradation as a therapeutic strategy for cancer
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids